Immix Biopharma IMMX
NASDAQ IMMX
$8.66 +0.31 (+3.71%)
As of: Nov 11, 2026 · 3:59 PM EST

Immix Biopharma (IMMX) Non Operating Interest Expenses (2021 - 2022)

Updated

Immix Biopharma's Non Operating Interest Expenses came in at $497.00 for FY2022, down 99.7% from $179,853 in FY2021.

Analysis

Immix Biopharma (IMMX) Non Operating Interest Expenses (2021 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put Non Operating Interest Expenses at $179,853 in FY2021 (+76.4%) and $101,976 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Immix Biopharma 597.32 Mn 365.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 109.00
Mar 31, 2022 388.00
Dec 31, 2021 44,507.00
Sep 30, 2021 53,937.00
Jun 30, 2021 53,865.00
Mar 31, 2021 27,544.00
API Access

Immix Biopharma Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IMMX&period=max&api_key=YOUR_API_KEY